Vertex Pharmaceuticals (Canada) Incorporated

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vertex Pharmaceuticals (Canada) Incorporated.The latest application filed is for "compounds and methods for the treatment or prevention of flavivirus infections".

Company Profile

0.7.6

Vertex Pharmaceuticals (Canada) Incorporated - Laval N/A CA
Vertex Pharmaceuticals (Canada) Incorporated - Canada

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods for the treatment or prevention of Flavivirus infections Grant 8,829,030 - Chan Chun Kong , et al. September 9, 2	2014-09-09
Compounds And Methods For The Treatment Or Prevention Of Flavivirus Infections App 20130123242 - Chan Chun Kong; Laval ; et al.	2013-05-16
Compounds And Methods For The Treatment Or Prevention Of Flavivirus Infections App 20130096106 - Chan Chun Kong; Laval ; et al.	2013-04-18
Compounds and methods for the treatment or prevention of flavivirus infections Grant 8,357,718 - Chan Chun Kong , et al. January 22, 2	2013-01-22
Compounds and methods for the treatment or prevention of Flavivirus infections Grant 8,329,924 - Chan Chun Kong , et al. December 11, 2	2012-12-11
Thiophene Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20120301430 - Chan Chun Kong; Laval ; et al.	2012-11-29
Thiophene analogues for the treatment or prevention of flavivirus infections Grant 8,269,014 - Chan Chun Kong , et al. September 18, 2	2012-09-18
Compounds and Methods for the Treatment or Prevention of Flavivirus Infections App 20120164103 - Denis; Real ; et al.	2012-06-28
Compounds and methods for the treatment or prevention of Flavivirus infections Grant 8,158,675 - Denis , et al. April 17, 2	2012-04-17
Thiophene Analogues For The Treatment Or Prevention Of Flavivirus Infections App 20120059170 - Chan Chun Kong; Laval ; et al.	2012-03-08
Thiophene analogues for the treatment or prevention of flavivirus infections Grant 8,003,685 - Chan Chun Kong , et al. August 23, 2	2011-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.